Kazia Therapeutics Limited (KZIA)
NASDAQ: KZIA · Real-Time Price · USD
14.50
+0.58 (4.17%)
At close: Jun 26, 2026, 4:00 PM EDT
14.22
-0.28 (-1.93%)
After-hours: Jun 26, 2026, 4:10 PM EDT
Kazia Therapeutics Market Cap
Kazia Therapeutics has a market cap or net worth of $162.49 million as of June 26, 2026. Its market cap has increased by 1,423.68% in one year.
Market Cap
162.49M
Enterprise Value
116.23M
1-Year Change
1,423.68%
Ranking
Category
Stock Price
$14.50
Market Cap Chart
Since September 1, 1999, Kazia Therapeutics's market cap has increased from $141.44M to $162.49M, an increase of 14.88%. That is a compound annual growth rate of 0.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 162.49M | 108.04% |
| Dec 31, 2025 | 78.10M | 913.26% |
| Dec 31, 2024 | 7.71M | -33.47% |
| Dec 29, 2023 | 11.59M | 15.31% |
| Dec 30, 2022 | 10.05M | -90.96% |
| Dec 31, 2021 | 111.18M | 11.75% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pyxis Oncology | 175.49M |
| Acumen Pharmaceuticals | 170.46M |
| Innate Pharma | 169.63M |
| Milestone Pharmaceuticals | 168.70M |
| Caribou Biosciences | 166.62M |
| YD Bio | 165.25M |
| Corbus Pharmaceuticals Holdings | 161.93M |
| ProQR Therapeutics | 161.20M |